Volume : 8
Issue : S1
An integrative review on development of COVID vaccine
Fatima R, Bilolikar AK, Reddy SG, Banerjee J
Pdf Page Numbers :- 117-123
Rafath Fatima1,*, Anil Kumar Bilolikar1, Sukrutha Gopal Reddy1, and Jaya Banerjee1
1Department Laboratory Medicine, Krishna Institute of Medical Sciences, Minister Road, Secunderabad-500003.Telangana, India
*Corresponding author: Dr. Rafath Fatima, MD, DNB (Microbiology), Department Laboratory Medicine, Krishna Institute of Medical Sciences, Minister Road, Secunderabad-500003, Telangana, India. Email: firstname.lastname@example.org
Received 15 September 2020; Revised 7 November 2020; Accepted 14 November 2020; Published 23 November 2020
Citation: Fatima R, Bilolikar AK, Reddy SG, Banerjee J. An integrative review on development of COVID vaccine. J Med Sci Res. 2020; 8(S1):117-123. DOI: http://dx.doi.org/10.17727/JMSR.2020/8S1-15
Copyright: © 2020 Fatima R et al. Published by KIMS Foundation and Research Center. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
View Full Text
The world is in dire need of safe, effective coronavirus disease 2019 (COVID-19) vaccine strategies. Since its emergence in November 2019, it has spread to 188 countries and 25 territories around the globe, despite elaborate efforts by World Health Organization (WHO) and governments to contain the infection, primarily owing to the highly infectious nature of this virus. Present article reviews various aspects in process of vaccine designing, vaccine platforms and current efforts and progress of COVID-19 vaccine candidates. The founding of the COVID-19 vaccines global access (COVAX) facility by Gavi, the coalition for epidemic preparedness innovations (CEPI) and the WHO is an attempt to garner resources and unite higher- and lower-income countries for the coordinated, rapid, transparent and equitable access to COVID-19 vaccines worldwide.
Keywords: vaccine strategies; COVAX; COVID-19; SARS-CoV-2